BiPar Sciences
Innovative therapies harnessing the power of PARP inhibitors to combat advanced cancers
General Information
BounceWatch is an independent company data service, not affiliated with BiPar Sciences. To contact BiPar Sciences, visit biparsciences.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does BiPar Sciences compare?
A PDF of BiPar Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting BiPar Sciences soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is BiPar Sciences on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About BiPar Sciences
Business keywords: BiPar Sciences, PARP inhibitors, cancer therapies, BSI-201, oncology, venture capital, acquisition, Sanofi-Aventis, clinical trials, breast cancer, ovarian cancer, tumor treatment, drug development, pharmaceutical industry
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | $20.00M | 7 |
|
12 Jan 2009 |
| Series B | $625.00K | 2 |
|
16 Apr 2008 |
| Series A | Undisclosed | 1 |
|
01 Jan 2008 |
| Series B | $35.00M | 7 |
|
26 Feb 2007 |
| Debt Financing | $5.00M | 1 |
Lighthouse Capital Partners
|
14 Jun 2006 |
| Debt Financing | $1.34M | 1 |
Asset Management Company
|
18 Oct 2005 |
| Venture Round | Undisclosed | 1 |
|
01 Jan 2005 |
| Series A | $13.00M | 6 |
|
20 Dec 2004 |
BiPar Sciences Alternatives & Competitors
View All Alternatives
Targeting Osteosarcoma, Breast Cancer and other Solid Tumors to prevent HER2-metastasis and destroy...
We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...
A biopharmaceutical company developing innovative cell therapy platforms for patients with cancer (N...
FAQ About BiPar Sciences
Source: BounceWatch company record for BiPar Sciences, https://bouncewatch.com/company/bipar-sciences, updated 11 September 2024. When citing, please name BounceWatch and link this page.
